SARTORIUS STED BIO (EPA:DIM) | WebDisclosure

Basculer en Français

10605	Companies
225017	Keywords
153738	Articles
119078	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 02/06/2026 at 11:45, 4 months 15 days ago

Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros
Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros for fiscal 2025, with total distributed profit of 67.1 million euros. Annual Shareholders' Meeting scheduled for March 24, 2026

Board Of Directors Financial Results Dividend Proposal Sartorius Stedim Biotech Annual Shareholders' Meeting
PRESS RELEASE

published on 02/06/2026 at 11:45, 4 months 15 days ago

Le Conseil d’administration de Sartorius Stedim Biotech S.A. approuve une proposition de dividende de 0,69 euro
Le Conseil d’administration de Sartorius Stedim Biotech S.A. approuve une proposition de dividende de 0,69 euro. L'AG des actionnaires se tiendra le 24 mars 2026

Actionnaires Sartorius Stedim Biotech Dividende Proposition AG
BRIEF

published on 02/03/2026 at 07:20, 4 months 18 days ago

Sartorius Stedim Biotech is recording significant growth in 2025

EBITDA Revenue Sartorius Stedim Biotech Growth 2025 Consumables
BRIEF

published on 02/03/2026 at 07:20, 4 months 18 days ago

Sartorius Stedim Biotech enregistre une croissance notable en 2025

Chiffre D'affaires EBITDA Sartorius Stedim Biotech Croissance 2025 Consommables
PRESS RELEASE

published on 02/03/2026 at 07:15, 4 months 18 days ago

Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives
Sartorius Stedim Biotech réalise une croissance rentable en 2025 avec un chiffre d'affaires en hausse de 9,6 %. Perspectives positives pour 2026

Chiffre D'affaires Sartorius Stedim Biotech Croissance Rentable Perspectives 2026
BRIEF

published on 02/03/2026 at 07:05, 4 months 18 days ago

Sartorius Stedim Biotech records strong growth in 2025

EBITDA Biotechnology Sartorius Growth 2025 Consumables
BRIEF

published on 02/03/2026 at 07:05, 4 months 18 days ago

Sartorius Stedim Biotech enregistre une solide croissance en 2025

EBITDA Biotechnologie Sartorius Croissance 2025 Consommables
PRESS RELEASE

published on 02/03/2026 at 07:00, 4 months 18 days ago

Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives
Sartorius Stedim Biotech réalise une croissance rentable en 2025 et maintient des perspectives positives. Chiffre d'affaires en hausse de 9,6% à taux de change constants. EBITDA à 914 millions d'euros. Perspectives de croissance rentable pour 2026

Chiffre D'affaires EBITDA Sartorius Stedim Biotech Croissance Rentable Perspectives Positives
PRESS RELEASE

published on 02/03/2026 at 07:00, 4 months 18 days ago

Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook
Sartorius Stedim Biotech achieves significant profitable growth in 2025 with unaudited sales revenue up 9.6% in constant currencies. Management expects continued growth in 2026

Financial Results Sartorius Stedim Biotech Profitable Growth 2025 2026
BRIEF

published on 02/02/2026 at 14:01, 4 months 19 days ago

Sartorius Stedim Biotech Discloses Share and Voting Rights Structure

Voting Rights Sartorius Stedim Biotech Regulatory Disclosure Issued Capital Share Structure

Accesswire

Published on 06/22/2026 at 03:00, 1 hour 40 minutes ago

Tunkillia Pre-Feasibility Study Begins
Published on 06/20/2026 at 01:00, 2 days 3 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 4 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 3 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 04:05, 34 minutes ago

Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 7 hours ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 22 hours ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 8 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 8 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité

Les Echos

Published on 06/19/2026 at 19:33, 2 days 9 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 9 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 9 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 9 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 2 days 9 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE